Global Oligonucleotides Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 259435
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Oligonucleotides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Oligonucleotides market size is estimated to be worth US$ 1290.3 million in 2021 and is forecast to a readjusted size of USD 2461.4 million by 2028 with a CAGR of 9.7% during review period. Pharmaceutical accounting for % of the Oligonucleotides global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DNA Oligos segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Oligonucleotides include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, and L.G.C Biosearch Technologies, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Oligonucleotides market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

DNA Oligos

RNA Oligos

Market segment by Application, can be divided into

Pharmaceutical

Research

Diagnostic

Market segment by players, this report covers

Integrated DNA Technologies

Agilent

Sigma-aldrich

Eurofins Genomics

L.G.C Biosearch Technologies

Eurogentec S.A

Nitto Denko Avecia Inc

GenScript

BBI Life Sciences

GeneDesign

TriLink BioTechnologies

SGS DNA

LC Sciences

Twist Bioscience

Creative Biogene

General Biosystems

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Oligonucleotides product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Oligonucleotides, with revenue, gross margin and global market share of Oligonucleotides from 2019 to 2022.

Chapter 3, the Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Oligonucleotides market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Oligonucleotides research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Oligonucleotides

1.2 Classification of Oligonucleotides by Type

1.2.1 Overview: Global Oligonucleotides Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Oligonucleotides Revenue Market Share by Type in 2021

1.2.3 DNA Oligos

1.2.4 RNA Oligos

1.3 Global Oligonucleotides Market by Application

1.3.1 Overview: Global Oligonucleotides Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Pharmaceutical

1.3.3 Research

1.3.4 Diagnostic

1.4 Global Oligonucleotides Market Size & Forecast

1.5 Global Oligonucleotides Market Size and Forecast by Region

1.5.1 Global Oligonucleotides Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Oligonucleotides Market Size by Region, (2017-2022)

1.5.3 North America Oligonucleotides Market Size and Prospect (2017-2028)

1.5.4 Europe Oligonucleotides Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Oligonucleotides Market Size and Prospect (2017-2028)

1.5.6 South America Oligonucleotides Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Oligonucleotides Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Oligonucleotides Market Drivers

1.6.2 Oligonucleotides Market Restraints

1.6.3 Oligonucleotides Trends Analysis

2 Company Profiles

2.1 Integrated DNA Technologies

2.1.1 Integrated DNA Technologies Details

2.1.2 Integrated DNA Technologies Major Business

2.1.3 Integrated DNA Technologies Oligonucleotides Product and Solutions

2.1.4 Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Integrated DNA Technologies Recent Developments and Future Plans

2.2 Agilent

2.2.1 Agilent Details

2.2.2 Agilent Major Business

2.2.3 Agilent Oligonucleotides Product and Solutions

2.2.4 Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Agilent Recent Developments and Future Plans

2.3 Sigma-aldrich

2.3.1 Sigma-aldrich Details

2.3.2 Sigma-aldrich Major Business

2.3.3 Sigma-aldrich Oligonucleotides Product and Solutions

2.3.4 Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Sigma-aldrich Recent Developments and Future Plans

2.4 Eurofins Genomics

2.4.1 Eurofins Genomics Details

2.4.2 Eurofins Genomics Major Business

2.4.3 Eurofins Genomics Oligonucleotides Product and Solutions

2.4.4 Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Eurofins Genomics Recent Developments and Future Plans

2.5 L.G.C Biosearch Technologies

2.5.1 L.G.C Biosearch Technologies Details

2.5.2 L.G.C Biosearch Technologies Major Business

2.5.3 L.G.C Biosearch Technologies Oligonucleotides Product and Solutions

2.5.4 L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 L.G.C Biosearch Technologies Recent Developments and Future Plans

2.6 Eurogentec S.A

2.6.1 Eurogentec S.A Details

2.6.2 Eurogentec S.A Major Business

2.6.3 Eurogentec S.A Oligonucleotides Product and Solutions

2.6.4 Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Eurogentec S.A Recent Developments and Future Plans

2.7 Nitto Denko Avecia Inc

2.7.1 Nitto Denko Avecia Inc Details

2.7.2 Nitto Denko Avecia Inc Major Business

2.7.3 Nitto Denko Avecia Inc Oligonucleotides Product and Solutions

2.7.4 Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Nitto Denko Avecia Inc Recent Developments and Future Plans

2.8 GenScript

2.8.1 GenScript Details

2.8.2 GenScript Major Business

2.8.3 GenScript Oligonucleotides Product and Solutions

2.8.4 GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 GenScript Recent Developments and Future Plans

2.9 BBI Life Sciences

2.9.1 BBI Life Sciences Details

2.9.2 BBI Life Sciences Major Business

2.9.3 BBI Life Sciences Oligonucleotides Product and Solutions

2.9.4 BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 BBI Life Sciences Recent Developments and Future Plans

2.10 GeneDesign

2.10.1 GeneDesign Details

2.10.2 GeneDesign Major Business

2.10.3 GeneDesign Oligonucleotides Product and Solutions

2.10.4 GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 GeneDesign Recent Developments and Future Plans

2.11 TriLink BioTechnologies

2.11.1 TriLink BioTechnologies Details

2.11.2 TriLink BioTechnologies Major Business

2.11.3 TriLink BioTechnologies Oligonucleotides Product and Solutions

2.11.4 TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 TriLink BioTechnologies Recent Developments and Future Plans

2.12 SGS DNA

2.12.1 SGS DNA Details

2.12.2 SGS DNA Major Business

2.12.3 SGS DNA Oligonucleotides Product and Solutions

2.12.4 SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 SGS DNA Recent Developments and Future Plans

2.13 LC Sciences

2.13.1 LC Sciences Details

2.13.2 LC Sciences Major Business

2.13.3 LC Sciences Oligonucleotides Product and Solutions

2.13.4 LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 LC Sciences Recent Developments and Future Plans

2.14 Twist Bioscience

2.14.1 Twist Bioscience Details

2.14.2 Twist Bioscience Major Business

2.14.3 Twist Bioscience Oligonucleotides Product and Solutions

2.14.4 Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Twist Bioscience Recent Developments and Future Plans

2.15 Creative Biogene

2.15.1 Creative Biogene Details

2.15.2 Creative Biogene Major Business

2.15.3 Creative Biogene Oligonucleotides Product and Solutions

2.15.4 Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Creative Biogene Recent Developments and Future Plans

2.16 General Biosystems

2.16.1 General Biosystems Details

2.16.2 General Biosystems Major Business

2.16.3 General Biosystems Oligonucleotides Product and Solutions

2.16.4 General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 General Biosystems Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Oligonucleotides Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Oligonucleotides Players Market Share in 2021

3.2.2 Top 10 Oligonucleotides Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Oligonucleotides Players Head Office, Products and Services Provided

3.4 Oligonucleotides Mergers & Acquisitions

3.5 Oligonucleotides New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Oligonucleotides Revenue and Market Share by Type (2017-2022)

4.2 Global Oligonucleotides Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Oligonucleotides Revenue Market Share by Application (2017-2022)

5.2 Global Oligonucleotides Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Oligonucleotides Revenue by Type (2017-2028)

6.2 North America Oligonucleotides Revenue by Application (2017-2028)

6.3 North America Oligonucleotides Market Size by Country

6.3.1 North America Oligonucleotides Revenue by Country (2017-2028)

6.3.2 United States Oligonucleotides Market Size and Forecast (2017-2028)

6.3.3 Canada Oligonucleotides Market Size and Forecast (2017-2028)

6.3.4 Mexico Oligonucleotides Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Oligonucleotides Revenue by Type (2017-2028)

7.2 Europe Oligonucleotides Revenue by Application (2017-2028)

7.3 Europe Oligonucleotides Market Size by Country

7.3.1 Europe Oligonucleotides Revenue by Country (2017-2028)

7.3.2 Germany Oligonucleotides Market Size and Forecast (2017-2028)

7.3.3 France Oligonucleotides Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Oligonucleotides Market Size and Forecast (2017-2028)

7.3.5 Russia Oligonucleotides Market Size and Forecast (2017-2028)

7.3.6 Italy Oligonucleotides Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Oligonucleotides Revenue by Type (2017-2028)

8.2 Asia-Pacific Oligonucleotides Revenue by Application (2017-2028)

8.3 Asia-Pacific Oligonucleotides Market Size by Region

8.3.1 Asia-Pacific Oligonucleotides Revenue by Region (2017-2028)

8.3.2 China Oligonucleotides Market Size and Forecast (2017-2028)

8.3.3 Japan Oligonucleotides Market Size and Forecast (2017-2028)

8.3.4 South Korea Oligonucleotides Market Size and Forecast (2017-2028)

8.3.5 India Oligonucleotides Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Oligonucleotides Market Size and Forecast (2017-2028)

8.3.7 Australia Oligonucleotides Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Oligonucleotides Revenue by Type (2017-2028)

9.2 South America Oligonucleotides Revenue by Application (2017-2028)

9.3 South America Oligonucleotides Market Size by Country

9.3.1 South America Oligonucleotides Revenue by Country (2017-2028)

9.3.2 Brazil Oligonucleotides Market Size and Forecast (2017-2028)

9.3.3 Argentina Oligonucleotides Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Oligonucleotides Revenue by Type (2017-2028)

10.2 Middle East & Africa Oligonucleotides Revenue by Application (2017-2028)

10.3 Middle East & Africa Oligonucleotides Market Size by Country

10.3.1 Middle East & Africa Oligonucleotides Revenue by Country (2017-2028)

10.3.2 Turkey Oligonucleotides Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Oligonucleotides Market Size and Forecast (2017-2028)

10.3.4 UAE Oligonucleotides Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Oligonucleotides Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Oligonucleotides Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Oligonucleotides Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Oligonucleotides Revenue (USD Million) by Region (2017-2022)

Table 5. Global Oligonucleotides Revenue Market Share by Region (2023-2028)

Table 6. Integrated DNA Technologies Corporate Information, Head Office, and Major Competitors

Table 7. Integrated DNA Technologies Major Business

Table 8. Integrated DNA Technologies Oligonucleotides Product and Solutions

Table 9. Integrated DNA Technologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Agilent Corporate Information, Head Office, and Major Competitors

Table 11. Agilent Major Business

Table 12. Agilent Oligonucleotides Product and Solutions

Table 13. Agilent Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Sigma-aldrich Corporate Information, Head Office, and Major Competitors

Table 15. Sigma-aldrich Major Business

Table 16. Sigma-aldrich Oligonucleotides Product and Solutions

Table 17. Sigma-aldrich Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Eurofins Genomics Corporate Information, Head Office, and Major Competitors

Table 19. Eurofins Genomics Major Business

Table 20. Eurofins Genomics Oligonucleotides Product and Solutions

Table 21. Eurofins Genomics Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. L.G.C Biosearch Technologies Corporate Information, Head Office, and Major Competitors

Table 23. L.G.C Biosearch Technologies Major Business

Table 24. L.G.C Biosearch Technologies Oligonucleotides Product and Solutions

Table 25. L.G.C Biosearch Technologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Eurogentec S.A Corporate Information, Head Office, and Major Competitors

Table 27. Eurogentec S.A Major Business

Table 28. Eurogentec S.A Oligonucleotides Product and Solutions

Table 29. Eurogentec S.A Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Nitto Denko Avecia Inc Corporate Information, Head Office, and Major Competitors

Table 31. Nitto Denko Avecia Inc Major Business

Table 32. Nitto Denko Avecia Inc Oligonucleotides Product and Solutions

Table 33. Nitto Denko Avecia Inc Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. GenScript Corporate Information, Head Office, and Major Competitors

Table 35. GenScript Major Business

Table 36. GenScript Oligonucleotides Product and Solutions

Table 37. GenScript Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. BBI Life Sciences Corporate Information, Head Office, and Major Competitors

Table 39. BBI Life Sciences Major Business

Table 40. BBI Life Sciences Oligonucleotides Product and Solutions

Table 41. BBI Life Sciences Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. GeneDesign Corporate Information, Head Office, and Major Competitors

Table 43. GeneDesign Major Business

Table 44. GeneDesign Oligonucleotides Product and Solutions

Table 45. GeneDesign Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. TriLink BioTechnologies Corporate Information, Head Office, and Major Competitors

Table 47. TriLink BioTechnologies Major Business

Table 48. TriLink BioTechnologies Oligonucleotides Product and Solutions

Table 49. TriLink BioTechnologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. SGS DNA Corporate Information, Head Office, and Major Competitors

Table 51. SGS DNA Major Business

Table 52. SGS DNA Oligonucleotides Product and Solutions

Table 53. SGS DNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. LC Sciences Corporate Information, Head Office, and Major Competitors

Table 55. LC Sciences Major Business

Table 56. LC Sciences Oligonucleotides Product and Solutions

Table 57. LC Sciences Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Twist Bioscience Corporate Information, Head Office, and Major Competitors

Table 59. Twist Bioscience Major Business

Table 60. Twist Bioscience Oligonucleotides Product and Solutions

Table 61. Twist Bioscience Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Creative Biogene Corporate Information, Head Office, and Major Competitors

Table 63. Creative Biogene Major Business

Table 64. Creative Biogene Oligonucleotides Product and Solutions

Table 65. Creative Biogene Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. General Biosystems Corporate Information, Head Office, and Major Competitors

Table 67. General Biosystems Major Business

Table 68. General Biosystems Oligonucleotides Product and Solutions

Table 69. General Biosystems Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Global Oligonucleotides Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 71. Global Oligonucleotides Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 72. Breakdown of Oligonucleotides by Company Type (Tier 1, Tier 2 and Tier 3)

Table 73. Oligonucleotides Players Head Office, Products and Services Provided

Table 74. Oligonucleotides Mergers & Acquisitions in the Past Five Years

Table 75. Oligonucleotides New Entrants and Expansion Plans

Table 76. Global Oligonucleotides Revenue (USD Million) by Type (2017-2022)

Table 77. Global Oligonucleotides Revenue Share by Type (2017-2022)

Table 78. Global Oligonucleotides Revenue Forecast by Type (2023-2028)

Table 79. Global Oligonucleotides Revenue by Application (2017-2022)

Table 80. Global Oligonucleotides Revenue Forecast by Application (2023-2028)

Table 81. North America Oligonucleotides Revenue by Type (2017-2022) & (USD Million)

Table 82. North America Oligonucleotides Revenue by Type (2023-2028) & (USD Million)

Table 83. North America Oligonucleotides Revenue by Application (2017-2022) & (USD Million)

Table 84. North America Oligonucleotides Revenue by Application (2023-2028) & (USD Million)

Table 85. North America Oligonucleotides Revenue by Country (2017-2022) & (USD Million)

Table 86. North America Oligonucleotides Revenue by Country (2023-2028) & (USD Million)

Table 87. Europe Oligonucleotides Revenue by Type (2017-2022) & (USD Million)

Table 88. Europe Oligonucleotides Revenue by Type (2023-2028) & (USD Million)

Table 89. Europe Oligonucleotides Revenue by Application (2017-2022) & (USD Million)

Table 90. Europe Oligonucleotides Revenue by Application (2023-2028) & (USD Million)

Table 91. Europe Oligonucleotides Revenue by Country (2017-2022) & (USD Million)

Table 92. Europe Oligonucleotides Revenue by Country (2023-2028) & (USD Million)

Table 93. Asia-Pacific Oligonucleotides Revenue by Type (2017-2022) & (USD Million)

Table 94. Asia-Pacific Oligonucleotides Revenue by Type (2023-2028) & (USD Million)

Table 95. Asia-Pacific Oligonucleotides Revenue by Application (2017-2022) & (USD Million)

Table 96. Asia-Pacific Oligonucleotides Revenue by Application (2023-2028) & (USD Million)

Table 97. Asia-Pacific Oligonucleotides Revenue by Region (2017-2022) & (USD Million)

Table 98. Asia-Pacific Oligonucleotides Revenue by Region (2023-2028) & (USD Million)

Table 99. South America Oligonucleotides Revenue by Type (2017-2022) & (USD Million)

Table 100. South America Oligonucleotides Revenue by Type (2023-2028) & (USD Million)

Table 101. South America Oligonucleotides Revenue by Application (2017-2022) & (USD Million)

Table 102. South America Oligonucleotides Revenue by Application (2023-2028) & (USD Million)

Table 103. South America Oligonucleotides Revenue by Country (2017-2022) & (USD Million)

Table 104. South America Oligonucleotides Revenue by Country (2023-2028) & (USD Million)

Table 105. Middle East & Africa Oligonucleotides Revenue by Type (2017-2022) & (USD Million)

Table 106. Middle East & Africa Oligonucleotides Revenue by Type (2023-2028) & (USD Million)

Table 107. Middle East & Africa Oligonucleotides Revenue by Application (2017-2022) & (USD Million)

Table 108. Middle East & Africa Oligonucleotides Revenue by Application (2023-2028) & (USD Million)

Table 109. Middle East & Africa Oligonucleotides Revenue by Country (2017-2022) & (USD Million)

Table 110. Middle East & Africa Oligonucleotides Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Oligonucleotides Picture

Figure 2. Global Oligonucleotides Revenue Market Share by Type in 2021

Figure 3. DNA Oligos

Figure 4. RNA Oligos

Figure 5. Oligonucleotides Revenue Market Share by Application in 2021

Figure 6. Pharmaceutical Picture

Figure 7. Research Picture

Figure 8. Diagnostic Picture

Figure 9. Global Oligonucleotides Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Oligonucleotides Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Oligonucleotides Revenue Market Share by Region (2017-2028)

Figure 12. Global Oligonucleotides Revenue Market Share by Region in 2021

Figure 13. North America Oligonucleotides Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Oligonucleotides Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Oligonucleotides Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Oligonucleotides Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Oligonucleotides Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Oligonucleotides Market Drivers

Figure 19. Oligonucleotides Market Restraints

Figure 20. Oligonucleotides Market Trends

Figure 21. Integrated DNA Technologies Recent Developments and Future Plans

Figure 22. Agilent Recent Developments and Future Plans

Figure 23. Sigma-aldrich Recent Developments and Future Plans

Figure 24. Eurofins Genomics Recent Developments and Future Plans

Figure 25. L.G.C Biosearch Technologies Recent Developments and Future Plans

Figure 26. Eurogentec S.A Recent Developments and Future Plans

Figure 27. Nitto Denko Avecia Inc Recent Developments and Future Plans

Figure 28. GenScript Recent Developments and Future Plans

Figure 29. BBI Life Sciences Recent Developments and Future Plans

Figure 30. GeneDesign Recent Developments and Future Plans

Figure 31. TriLink BioTechnologies Recent Developments and Future Plans

Figure 32. SGS DNA Recent Developments and Future Plans

Figure 33. LC Sciences Recent Developments and Future Plans

Figure 34. Twist Bioscience Recent Developments and Future Plans

Figure 35. Creative Biogene Recent Developments and Future Plans

Figure 36. General Biosystems Recent Developments and Future Plans

Figure 37. Global Oligonucleotides Revenue Share by Players in 2021

Figure 38. Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 39. Global Top 3 Players Oligonucleotides Revenue Market Share in 2021

Figure 40. Global Top 10 Players Oligonucleotides Revenue Market Share in 2021

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 42. Global Oligonucleotides Revenue Share by Type in 2021

Figure 43. Global Oligonucleotides Market Share Forecast by Type (2023-2028)

Figure 44. Global Oligonucleotides Revenue Share by Application in 2021

Figure 45. Global Oligonucleotides Market Share Forecast by Application (2023-2028)

Figure 46. North America Oligonucleotides Sales Market Share by Type (2017-2028)

Figure 47. North America Oligonucleotides Sales Market Share by Application (2017-2028)

Figure 48. North America Oligonucleotides Revenue Market Share by Country (2017-2028)

Figure 49. United States Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Canada Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Mexico Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Europe Oligonucleotides Sales Market Share by Type (2017-2028)

Figure 53. Europe Oligonucleotides Sales Market Share by Application (2017-2028)

Figure 54. Europe Oligonucleotides Revenue Market Share by Country (2017-2028)

Figure 55. Germany Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. France Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. United Kingdom Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Russia Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Italy Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Asia-Pacific Oligonucleotides Sales Market Share by Type (2017-2028)

Figure 61. Asia-Pacific Oligonucleotides Sales Market Share by Application (2017-2028)

Figure 62. Asia-Pacific Oligonucleotides Revenue Market Share by Region (2017-2028)

Figure 63. China Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Japan Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South Korea Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. India Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Southeast Asia Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Australia Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South America Oligonucleotides Sales Market Share by Type (2017-2028)

Figure 70. South America Oligonucleotides Sales Market Share by Application (2017-2028)

Figure 71. South America Oligonucleotides Revenue Market Share by Country (2017-2028)

Figure 72. Brazil Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Argentina Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Middle East and Africa Oligonucleotides Sales Market Share by Type (2017-2028)

Figure 75. Middle East and Africa Oligonucleotides Sales Market Share by Application (2017-2028)

Figure 76. Middle East and Africa Oligonucleotides Revenue Market Share by Country (2017-2028)

Figure 77. Turkey Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Saudi Arabia Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. UAE Oligonucleotides Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz